Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

ROCKET PHARMACEUTICALS, INC. (RCKT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 4 Makker Gotham (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 10,312 shares @ $21.0318, valued at $216.9k
Sold 4,677 shares @ $21.1383, valued at $98.9k
08/21/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 1,534 shares @ $15.471, valued at $23.7k
08/21/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 4,767 shares @ $15.471, valued at $73.8k
08/21/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 284 shares @ $15.471, valued at $4.4k
08/15/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 725 restricted stock units @ $0
08/15/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 3,989 restricted stock units @ $0
08/15/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 7,979 restricted stock units @ $0
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/19/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 4,122 shares @ $21.375, valued at $88.1k
05/19/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 1,330 shares @ $21.375, valued at $28.4k
05/19/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 245 shares @ $21.375, valued at $5.2k
05/16/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 7,979 restricted stock units @ $0
05/16/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 725 restricted stock units @ $0
05/16/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 3,989 restricted stock units @ $0
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2023 4 RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Acquired 529,038 shares @ $0
Acquired 1 options to buy @ $40.0324, valued at $40
Acquired 61,705 warrants @ $65.23, valued at $4M
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/22/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/22/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
02/22/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
12/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/11/2022 4 RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Bought 1,355,932 shares @ $14.75, valued at $20M
08/16/2022 4 Schwartz Jonathan David (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 22,896 restricted stock units @ $0
08/16/2022 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 52,489 restricted stock units @ $0
08/16/2022 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 14,310 restricted stock units @ $0
08/16/2022 4 Wilson Martin (General Counsel) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 20,318 options to buy @ $17.47, valued at $355k
Granted 28,763 restricted stock units @ $0
06/15/2022 4 Malik Fady Ibraham (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Granted 47,745 options to buy @ $10.77, valued at $514.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy